VRAY ViewRay, Inc.

4.320.09 (+2.13%)
Close: December 13, 2019

4.370.05 (+1.16%)
After hours

Quote

Previous Close
$4.32
Day Range
$4.15-$4.32
52 Week Range
$2.12-$9.76
Volume
1,279,195
Avg Volume
3,135,510
Dividend TTM
-
Ex-Dividend Date
2015-07-08

Valuation

Market Cap
$635.86M
Enterprise Value (EV)
$510.54M
PE Ratio
-
EV/EBITDA
-7.12
Price/Sales
7.69
Price/Book
3.80
PEG Ratio
-

Financials

Revenue
$80.96M
Gross Profit
$6.60M
EBITDA
-$71.66M
EPS, ttm
-$1.05
Profit Margin
-
Revenue/Employee
$366.34K
Next Earnings Date
3/11/2020 (88 days)
Debt to Equity
33%
Debt
$42.12M
Cash
$167.43M
Net Debt
-

Performance

Beta
1.72
200 Day Moving Avg
$6.07
50 Day Moving Avg
$3.00
52 Week Change
-31.32%
YTD Change
-27.74%
1 Month Change
58.24%
3 Month Change
16.13%
6 Month Change
-50.63%
1 Year Change
-31.32%
2 Year Change
-52.31%
5 Year Change
-15.40%

Share Count

Shares Outstanding
147.2M
Float
97.5M
Restricted Shares
49.7M
Restricted Shares, %
33.77%

ViewRay, Inc. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Scott William Drake

Website: http://www.viewray.com

Description: ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

Employees: 221

Latest News